Responses
Regular and young investigator award abstracts
Immune-stimulants and immune modulators
574 ONM-400, a novel approach for interleukin-2 therapy using a ph-activated nanoparticle targeting metabolic acidosis in solid cancers
Compose a Response to This Article
Other responses
No responses have been published for this article.
